Page 1724 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1724
1530.e4 Part VII Hematologic Malignancies
118. Pecora AL, Lazarus HM, Jennis AA, et al: Breast cancer cell contamina- 120. Krause DS, Fackler MJ, Civin CI, et al: CD34: structure, biology, and
tion of blood stem cell products in patients with metastatic breast clinical utility. Blood 87(1):1–13, 1996.
cancer: predictors and clinical relevance. Biol Blood Marrow Transplant 121. Bender JG, Lum L, Unverzagt KL, et al: Correlation of colony-forming
8(10):536–543, 2002. cells, long-term culture initiating cells and CD34+ cells in apheresis
119. Passos-Coelho JL, Ross AA, Kahn DJ, et al: Similar breast cancer cell products from patients mobilized for peripheral blood progenitors with
contamination of single-day peripheral-blood progenitor-cell collec- different regimens. Bone Marrow Transplant 13(4):479–485, 1994.
tions obtained after priming with hematopoietic growth factor alone
or after cyclophosphamide followed by growth factor. J Clin Oncol
14(9):2569–2575, 1996.
